Riociguat in systemic sclerosis: challenges in crossing the bridge from bench to bedside

Lancet Rheumatol. 2023 Nov;5(11):e641-e643. doi: 10.1016/S2665-9913(23)00271-0.
No abstract available

MeSH terms

  • Humans
  • Pyrazoles* / therapeutic use
  • Pyrimidines / therapeutic use
  • Scleroderma, Systemic* / drug therapy

Substances

  • riociguat
  • Pyrazoles
  • Pyrimidines